Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

High-Throughput Screening for Novel Inhibitors of Intracellular Pathogens, Including Chlamydia trachomatis.

Brown AC, Kushner NL.

Methods Mol Biol. 2019;2042:279-286. doi: 10.1007/978-1-4939-9694-0_18.

PMID:
31385282
2.

The Deconstructed Granuloma: A Complex High-Throughput Drug Screening Platform for the Discovery of Host-Directed Therapeutics Against Tuberculosis.

Huang L, Kushner NL, Theriault ME, Pisu D, Tan S, McNamara CW, Petrassi HM, Russell DG, Brown AC.

Front Cell Infect Microbiol. 2018 Aug 14;8:275. doi: 10.3389/fcimb.2018.00275. eCollection 2018.

3.

Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits.

Subbian S, Bandyopadhyay N, Tsenova L, O'Brien P, Khetani V, Kushner NL, Peixoto B, Soteropoulos P, Bader JS, Karakousis PC, Fallows D, Kaplan G.

Cell Commun Signal. 2013 Aug 19;11:60. doi: 10.1186/1478-811X-11-60.

4.

Molecular immunologic correlates of spontaneous latency in a rabbit model of pulmonary tuberculosis.

Subbian S, O'Brien P, Kushner NL, Yang G, Tsenova L, Peixoto B, Bandyopadhyay N, Bader JS, Karakousis PC, Fallows D, Kaplan G.

Cell Commun Signal. 2013 Feb 28;11(1):16. doi: 10.1186/1478-811X-11-16.

5.

Spontaneous latency in a rabbit model of pulmonary tuberculosis.

Subbian S, Tsenova L, O'Brien P, Yang G, Kushner NL, Parsons S, Peixoto B, Fallows D, Kaplan G.

Am J Pathol. 2012 Nov;181(5):1711-24. doi: 10.1016/j.ajpath.2012.07.019. Epub 2012 Sep 5.

6.

Primary and secondary drug screening assays for Friedreich ataxia.

Cotticelli MG, Rasmussen L, Kushner NL, McKellip S, Sosa MI, Manouvakhova A, Feng S, White EL, Maddry JA, Heemskerk J, Oldt RJ, Surrey LF, Ochs R, Wilson RB.

J Biomol Screen. 2012 Mar;17(3):303-13. doi: 10.1177/1087057111427949. Epub 2011 Nov 15.

PMID:
22086726
7.

Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.

Williams-Aziz SL, Hartline CB, Harden EA, Daily SL, Prichard MN, Kushner NL, Beadle JR, Wan WB, Hostetler KY, Kern ER.

Antimicrob Agents Chemother. 2005 Sep;49(9):3724-33.

8.

In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication.

Kern ER, Kushner NL, Hartline CB, Williams-Aziz SL, Harden EA, Zhou S, Zemlicka J, Prichard MN.

Antimicrob Agents Chemother. 2005 Mar;49(3):1039-45.

9.

Inhibition of herpesvirus replication by a series of 4-oxo-dihydroquinolines with viral polymerase activity.

Hartline CB, Harden EA, Williams-Aziz SL, Kushner NL, Brideau RJ, Kern ER.

Antiviral Res. 2005 Feb;65(2):97-105.

PMID:
15708636
10.

Efficacy of methylenecyclopropane analogs of nucleosides against herpesvirus replication in vitro.

Kushner NL, Williams SL, Hartline CB, Harden EA, Bidanset DJ, Chen X, Zemlicka J, Kern ER.

Nucleosides Nucleotides Nucleic Acids. 2003 Dec;22(12):2105-19.

PMID:
14714760
11.

In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.

Williams SL, Hartline CB, Kushner NL, Harden EA, Bidanset DJ, Drach JC, Townsend LB, Underwood MR, Biron KK, Kern ER.

Antimicrob Agents Chemother. 2003 Jul;47(7):2186-92.

12.

Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.

Long MC, Bidanset DJ, Williams SL, Kushner NL, Kern ER.

Antiviral Res. 2003 Apr;58(2):149-57.

PMID:
12742575

Supplemental Content

Loading ...
Support Center